Earnings Outlook For AstraZeneca
Portfolio Pulse from Benzinga Insights
AstraZeneca (NASDAQ:AZN) is scheduled to release its quarterly earnings report on February 8, 2024, with analysts expecting an EPS of $0.79. The company's past earnings performance shows a mix of beats and misses, with the share price reacting variably. Shares are currently trading at $67.04, down 1.19% over the last 52 weeks. Investors are looking for positive guidance for the next quarter, which could significantly impact the stock price.
February 07, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AstraZeneca is expected to report an EPS of $0.79 for the upcoming quarter. The company's past earnings performance and the current share price trend indicate a cautious outlook among investors.
Given AstraZeneca's mixed past earnings performance and the slight downtrend in share price over the last year, the upcoming earnings report and particularly the guidance for the next quarter will be crucial. Positive guidance could lead to a positive short-term impact on the stock price, while a lack of positive outlook or a miss on earnings could further dampen investor sentiment.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100